Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 47c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.43), $0.47 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• BMO Capital Downgrades Westlake Chemical (WLK) to Market Perform
• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance